Don't Lose Your Footing on the Slope of Hope<br /><br />By Rev Shark<br />RealMoney.com Contributor<br />1/8/2008 7:49 AM EST<br /><br />Character is an essential tendency. It can be covered up, it can be messed with, it can be screwed around with, but it can't be ultimately changed. It's the structure of our bones, the blood that runs through our veins. <br />-- Sam Shepard<br /> <br /> <br />The poor employment report last Friday has helped to cement a change in market character. We are now in a downtrend, and the bears are in control. That doesn't mean we won't have a vigorous rally or some good action, but we need to assume that it will eventually fail rather than continue and take the market back to its highs. <br /><br />One of the easiest ways to lose money is to repeatedly chase long-side entries in a struggling market. There is a strong inclination to hope that a downward slide will suddenly end and a lasting rally will begin. In a market with bad character, the rallies fizzle quickly, and if you are overly aggressive on the long side you fund yourself suddenly stuck and having to take losses. <br /><br />In an uptrending market, a phenomenon known as "climbing the wall of worry" can keep things going. This occurs when investors doubt the sustainability of a rally because of a long list of worries and concerns. When the market fails to roll over, investors put some money to work because they don't want to be left out. That pushes the market higher and entices more people to inch in and keep things climbing higher. <br /><br />In a downtrending market, there is an opposite phenomenon knows as "sliding down the slope of hope." After the market takes a big hit, there is often hope that we will recover and start working our way back up. So investors start to put money back to work in hopes they will catch the bottom. When the market fails to deliver sustained upside, investors give up which pressures the market. That pressure causes more investors to become discouraged and more selling ensues. Hope prevents us from getting a complete washout, and instead we slowly slide lower as discouragement takes hold. <br /><br />I don't want to be vague about this. This market is now technically broken, and that means we need to be highly defensive and protect our capital. However, there is a very high likelihood we are going to see a strong bounce back up in the near term. I suspect the catalyst will be a move by the Fed. We will get a fast and furious rally on the news, but it will be used to unload positions and will fizzle fairly quickly. <br /><br />Plan your strategy accordingly and don't forget that the essential character of this market has changed. We are going to get a decent short-term rally, but in the longer run we are in for a rough time that is likely to last for a while. <br /><br />We have some positive action in the early going this morning. There isn't much news on the wires, but overseas markets were generally higher. Gold is up strongly and oil is bouncing back after taking a hit yesterday. <br /><br /><br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance/same store sales: AEHR +16.1%, RPM +7.9%, NEWP +7.0%, WBSN +5.9%, FRNT +1.4%... Other news: ISIS +35.1% (ISIS and Genzyme announce strategic alliance), SIRT +13.7% (announces positive results with proprietary version of Resveratrol, SRT501, in a Phase 1b Type 2 diabetes clinical study), VMED +7.4% (SRM Fund Management raises stake to 8.26% from 7.12%), SBUX +7.2% (announces strategic initiatives to increase shareholder value and Chairman Howard Schultz returns as CEO; also upgraded to Neutral at BofA), ZIXI +4.8% (extends distribution agreement with Google), PZE +3.7% (Cramer makes positive comments on MadMoney), EBS +2.5% (announces that the final Phase II clinical study results for Typhoid Vaccine reaffirms clinical endpoints met), NRGN +2.3% (announces results of multiple ascending dose studies with experimental obesity drug), GG +2.2% (Achieves record gold production in 2007), VSAT +1.9% (Eutelsat, ViaSat form strategic partnership - WSJ; also downgraded to Mkt Perform at Collins Stewart), MSO +1.6% (CEO Lyne will not leave company - Reuters), BSC +1.5% (CEO James Cayne to step down, sources say - WSJ), OMNI +1.5% (Chief Executive Officer James Eckert to retire in 2008), DOW +1.4% (Cramer makes positive comments on MadMoney), BP +1.3% (still checking), BMY +1.3% (Cramer makes positive comments on MadMoney), JEC +1.2% (receives contract from U.S. Air Force)... Analyst upgrades: PCS +6.3% (upgraded to Buy at Soleil), AUY +3.8% (upgraded to Outperform at CIBC), INFY +2.8% (upgraded to Overweight at Lehman), KGC +2.8% (upgraded to Outperform at CIBC), AEM +2.5% (upgraded to Outperform at CIBC), WIT +1.7% (upgraded to Overweight at Lehman), BAX +1.5% (upgraded to Buy from Hold at Citigroup).<br /><br />Allapoole avanevad:<br /><br />In reaction to weak earnings/guidance/same store sales: CMOS -8.8%, GRB -7.9%, BLUD -7.5%, DRAD -7.5%, EAT -6.2%, ATCO -3.7%, CC -1.9%, CSCX -1.6%... Other news: CROX -4.4% (Cowen says checks with industry contacts imply risk of continued inventory, margin concerns), SGEN -4.2% (earns milestone payment from initiation of SGN-40 Phase Ib clinical trial), CDNS -3.8% (still checking), ZLC -3.1% (Breeden Capital Management is gearing up for a proxy battle - NY Post), BSX -1.3% (announces court decision and no longer sells the NIR stent), ELOY -1.3% (announced that it has recently signed two additional Behavioral Analytics contracts), BAS -1.1% (reports selected operating data for December 2007)... Analyst downgrades: CC -7.1% (downgraded to Neutral at Cowen), EAT -6.2% (downgraded to Underweight at KeyBanc), ISRG -4.3% (downgraded to Market Perform at Wachovia), MHS -3.2% (hearing downgraded to Neutral at tier 1 firm), MIPS -3.0% (downgraded to Neutral at Longbow), AMWD -2.4% (initiated with a Sector Perform at CIBC), UNFI -2.0% (hearing downgraded to Sell at tier 1 firm), AMZN -1.9% (initiated with a Sell at Amtech), ITW -1.3% (downgraded to Neutral at Merrill Lynch), ALV -1.3% (hearing added to Pan-European Sell List at tier-1 firm), ROK -1.1% (downgraded to Sell at Merrill Lynch).